Sanofi

Latest Stories

Tommy Marshall, 56, of Atlanta, poses for a portrait on Tuesday, April 16, 2024, in Atlanta. Marshall who has type 1 diabetes, paid $251 dollars for four to eight weeks worth of medication in November. "Even if you can afford it, just paying that much for something that you know is a massive profit center for the drug company is challenging," said Marshall, a lifelong Democrat. He added of Biden, "If I was a his political consultant I'd be telling him to talk about it constantly." (AP Photo/Brynn Anderson)

Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut

By Will Weissert - Associated Press

Usher performs at the 51st annual Songwriters Hall of Fame induction and awards gala at the New York Marriott Marquis Hotel on Thursday, June 16, 2022, in New York. Usher will perform at the halftime show for the 2024 Super Bowl. (Photo by Charles Sykes/Invision/AP, File)

Usher uses first Super Bowl performance as ‘cheat sheet’ for 2024 show and urges diabetes screening

By Jonathan Landrum Jr. - Associated Press

This photo shows signage outside the Amgen headquarters in Thousand Oaks, Calif on Nov. 9, 2014. Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion. (AP Photo/Mark J. Terrill, File)

Amgen to buy Horizon Therapeutics in $26.4B deal

By Tom Murphy - Associated Press

French drug company Sanofi drops plan for mRNA-based COVID-19 vaccine

By Shen Wu Tan - The Washington Times

FILE - In this April 21, 2021, file photo, President Joe Biden speaks about COVID-19 vaccinations at the White House, in Washington. Biden spent his first 100 days encouraging Americans to mask up and stay home to slow the spread of COVID-19. His task for the next 100 will be to encourage the opposite behavior and manage the nation’s transition back to normalcy. (AP Photo/Evan Vucci, File)

‘Go get the shot’: Biden highlights path back to normal

By ZEKE MILLER - Associated Press

FILE - In this Feb. 12, 2021, file photo, scripps health official draws from a vile of the COVID-19 vaccine prior to administering it at their new drive-thru vaccination site at the Del Mar Fairgrounds in Del Mar, Calif. Executives from the major COVID-19 vaccine producers are set Tuesday, Feb. 23, to answer questions from Congress about expanding the supply of shots needed to curb the pandemic that has killed more than 500,000 Americans. (Nelvin C. Cepeda/The San Diego Union-Tribune via AP, Pool, File)

Drug executives: Big jump in vaccine supply is coming soon

By MATTHEW PERRONE and LAURAN NEERGAARD - Associated Press

Sanofi to help second rival produce COVID-19 vaccines

Associated Press

France’s Sanofi to help rival Pfizer-BioNTech make vaccines

By ANGELA CHARLTON - Associated Press

A nurse administrates a Pfizer/Biontech COVID-19 vaccine to a health care worker at the MontLegia CHC hospital in Liege, Belgium, Wednesday, Jan. 27, 2021. (AP Photo/Francisco Seco)

Sanofi says it will help Pfizer make vaccines for EU

By Tom Howell Jr. - The Washington Times

Striking workers gather outside the French pharmaceutical company Sanofi headquarters in Marcy l'Etoile, central France, Tuesday, Jan.19, 2021. Employees of pharmaceutical company Sanofi stage a protest against planned redundancies that they say could slow the fight against the Coronavirus pandemic . Sanofi had been developing Covid vaccines but will not be ready to roll out until late 2021. (AP Photo/Laurent Cipriani)

Unions strike over job cuts at French vaccine maker Sanofi

Associated Press

A nurse prepares a vaccine prior to the vaccination of elderly people at a nursing house in Athens, Monday, Jan. 4, 2021. Vaccinations were expanded from 9 to 50 hospitals nationwide on Monday. (Louisa Gouliamaki/Pool via AP)

EU rejects criticism for slow vaccine rollout across bloc

By SAMUEL PETREQUIN - Associated Press

Registered nurse Betty Hallman, left, gives registered nurse Norma Elizondo a shot of the Pfizer COVID-19 vaccine at University Hospital in Augusta, Ga., Tuesday, Dec. 22, 2020. (Michael Holahan/The Augusta Chronicle via AP)

Pfizer and BioNTech to supply the U.S. with additional 100M doses of the COVID-19 vaccine

By Tom Howell Jr. - The Washington Times

President Donald Trump speaks during an "Operation Warp Speed Vaccine Summit" on the White House complex, Tuesday, Dec. 8, 2020, in Washington. (AP Photo/Evan Vucci)

Trump praises Peter Marks, FDA official at center of vaccine approval

By Tom Howell Jr. - The Washington Times

A mannequin wears a face mask in front of outdoor seating at the Wipeout Bar and Grill at Pier 39 during the coronavirus outbreak in San Francisco, Thursday, Nov. 12, 2020. (AP Photo/Jeff Chiu)

Coronavirus spread in U.S. alarms officials as Americans grow weary of limits

By Tom Howell Jr. - The Washington Times

President Donald Trump speaks in the Rose Garden of the White House, Friday, Nov. 13, 2020, in Washington. (AP Photo/Evan Vucci)

Trump takes victory lap on coronavirus vaccine, says New York will have to wait for doses

By Tom Howell Jr. - The Washington Times

Sanofi, GSK to provide COVID-19 vaccine to global alliance

Associated Press

Department of Health and Human Services Secretary Alex Azar speaks during a White House Coronavirus Task Force briefing at the Department of Education building Wednesday, July 8, 2020, in Washington. (AP Photo/Manuel Balce Ceneta) ** FILE **

Trump administration to provide up to $2.1 billion to Sanofi, GSK for vaccine production

By David Sherfinski - The Washington Times

FILE - In this June 16, 2020, file photo, French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Laurent Cipriani, Pool)

US sinks another $2.1 billion into a potential vaccine

By DANICA KRKA - Associated Press

This undated handout photo provided by Imperial College London shows a COVID-19 vaccine candidate. Scientists at Imperial College London will start immunizing people in Britain this week with their experimental coronavirus shot, becoming the latest entry into the race to find an effective vaccine. In a statement on Monday, June 15, 2020 the British government said that 300 healthy people will be immunized with two doses of the COVID-19 vaccine candidate developed at Imperial College London, which has been backed by £41 million pounds ($51 million) in government funding. About a dozen vaccine candidates are in early stages of testing in thousands of people. (Imperial College London via AP)

UK begins coronavirus vaccine trial; France pledges funding

By MARIA CHENG and ANGELA CHARLTON - Associated Press

Novavax, Merck rise; Regeneron, Anaplan fall

Associated Press